Global Peripheral Arterial Disease (PAD) Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Peripheral Arterial Disease (PAD) Therapeutics market size was valued at US$ 2876.1 million in 2023. With growing demand in downstream market, the Peripheral Arterial Disease (PAD) Therapeutics is forecast to a readjusted size of US$ 4195.9 million by 2030 with a CAGR of 5.5% during review period.
The research report highlights the growth potential of the global Peripheral Arterial Disease (PAD) Therapeutics market. Peripheral Arterial Disease (PAD) Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peripheral Arterial Disease (PAD) Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peripheral Arterial Disease (PAD) Therapeutics market.
Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Peripheral Arterial Disease (PAD) Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peripheral Arterial Disease (PAD) Therapeutics market. It may include historical data, market segmentation by Type (e.g., Anti-Platelet Drugs, Dual Antiplatelet Therapy Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peripheral Arterial Disease (PAD) Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peripheral Arterial Disease (PAD) Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peripheral Arterial Disease (PAD) Therapeutics industry. This include advancements in Peripheral Arterial Disease (PAD) Therapeutics technology, Peripheral Arterial Disease (PAD) Therapeutics new entrants, Peripheral Arterial Disease (PAD) Therapeutics new investment, and other innovations that are shaping the future of Peripheral Arterial Disease (PAD) Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peripheral Arterial Disease (PAD) Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Peripheral Arterial Disease (PAD) Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peripheral Arterial Disease (PAD) Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peripheral Arterial Disease (PAD) Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peripheral Arterial Disease (PAD) Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peripheral Arterial Disease (PAD) Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peripheral Arterial Disease (PAD) Therapeutics market.
Market Segmentation:
Peripheral Arterial Disease (PAD) Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Peripheral Arterial Disease (PAD) Therapeutics market size was valued at US$ 2876.1 million in 2023. With growing demand in downstream market, the Peripheral Arterial Disease (PAD) Therapeutics is forecast to a readjusted size of US$ 4195.9 million by 2030 with a CAGR of 5.5% during review period.
The research report highlights the growth potential of the global Peripheral Arterial Disease (PAD) Therapeutics market. Peripheral Arterial Disease (PAD) Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peripheral Arterial Disease (PAD) Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peripheral Arterial Disease (PAD) Therapeutics market.
Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Peripheral Arterial Disease (PAD) Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peripheral Arterial Disease (PAD) Therapeutics market. It may include historical data, market segmentation by Type (e.g., Anti-Platelet Drugs, Dual Antiplatelet Therapy Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peripheral Arterial Disease (PAD) Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peripheral Arterial Disease (PAD) Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peripheral Arterial Disease (PAD) Therapeutics industry. This include advancements in Peripheral Arterial Disease (PAD) Therapeutics technology, Peripheral Arterial Disease (PAD) Therapeutics new entrants, Peripheral Arterial Disease (PAD) Therapeutics new investment, and other innovations that are shaping the future of Peripheral Arterial Disease (PAD) Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peripheral Arterial Disease (PAD) Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Peripheral Arterial Disease (PAD) Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peripheral Arterial Disease (PAD) Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peripheral Arterial Disease (PAD) Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peripheral Arterial Disease (PAD) Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peripheral Arterial Disease (PAD) Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peripheral Arterial Disease (PAD) Therapeutics market.
Market Segmentation:
Peripheral Arterial Disease (PAD) Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Anti-Platelet Drugs
- Dual Antiplatelet Therapy Drugs
- Others
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca Plc. (UK)
- Bayer HealthCare Pharmaceuticals (Germany)
- Bristol-Myers Squibb Company (US)
- Merck & Co., Inc. (US)
- Proteon Therapeutics, Inc. (US)
- Sanofi S.A. (France)
- Symic Bio, Inc. (US)
- TheraVasc Inc. (US)
- AnGes MG, Inc. (Japan)
- Athersys, Inc. (US)
- Betagenon AB (Sweden)
- miRagen Therapeutics, Inc. (US)
- Multi Gene Vascular Systems Ltd (Israel)
- ViroMed Co. Ltd. (Korea)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2030
2.1.2 Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
2.2.1 Anti-Platelet Drugs
2.2.2 Dual Antiplatelet Therapy Drugs
2.2.3 Others
2.3 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
2.3.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
2.5.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
3 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Players
3.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS BY REGIONS
4.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth (2019-2024)
4.3 APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth (2019-2024)
4.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2019-2024)
5.2 Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024)
5.3 Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2019-2024)
6.2 APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024)
6.3 APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peripheral Arterial Disease (PAD) Therapeutics by Country (2019-2024)
7.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024)
7.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET FORECAST
10.1 Global Peripheral Arterial Disease (PAD) Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Peripheral Arterial Disease (PAD) Therapeutics Forecast
10.1.3 APAC Peripheral Arterial Disease (PAD) Therapeutics Forecast
10.1.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Forecast
10.1.5 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Forecast
10.2 Americas Peripheral Arterial Disease (PAD) Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.2.2 Canada Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.2.3 Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.2.4 Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3 APAC Peripheral Arterial Disease (PAD) Therapeutics Forecast by Region (2025-2030)
10.3.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.3 Korea Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.4 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.5 India Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.6 Australia Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4.2 France Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4.3 UK Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4.4 Italy Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4.5 Russia Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5.2 South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5.3 Israel Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5.4 Turkey Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5.5 GCC Countries Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.6 Global Peripheral Arterial Disease (PAD) Therapeutics Forecast by Type (2025-2030)
10.7 Global Peripheral Arterial Disease (PAD) Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca Plc. (UK)
11.1.1 AstraZeneca Plc. (UK) Company Information
11.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Plc. (UK) Main Business Overview
11.1.5 AstraZeneca Plc. (UK) Latest Developments
11.2 Bayer HealthCare Pharmaceuticals (Germany)
11.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Information
11.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bayer HealthCare Pharmaceuticals (Germany) Main Business Overview
11.2.5 Bayer HealthCare Pharmaceuticals (Germany) Latest Developments
11.3 Bristol-Myers Squibb Company (US)
11.3.1 Bristol-Myers Squibb Company (US) Company Information
11.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bristol-Myers Squibb Company (US) Main Business Overview
11.3.5 Bristol-Myers Squibb Company (US) Latest Developments
11.4 Merck & Co., Inc. (US)
11.4.1 Merck & Co., Inc. (US) Company Information
11.4.2 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck & Co., Inc. (US) Main Business Overview
11.4.5 Merck & Co., Inc. (US) Latest Developments
11.5 Proteon Therapeutics, Inc. (US)
11.5.1 Proteon Therapeutics, Inc. (US) Company Information
11.5.2 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Proteon Therapeutics, Inc. (US) Main Business Overview
11.5.5 Proteon Therapeutics, Inc. (US) Latest Developments
11.6 Sanofi S.A. (France)
11.6.1 Sanofi S.A. (France) Company Information
11.6.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sanofi S.A. (France) Main Business Overview
11.6.5 Sanofi S.A. (France) Latest Developments
11.7 Symic Bio, Inc. (US)
11.7.1 Symic Bio, Inc. (US) Company Information
11.7.2 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Symic Bio, Inc. (US) Main Business Overview
11.7.5 Symic Bio, Inc. (US) Latest Developments
11.8 TheraVasc Inc. (US)
11.8.1 TheraVasc Inc. (US) Company Information
11.8.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 TheraVasc Inc. (US) Main Business Overview
11.8.5 TheraVasc Inc. (US) Latest Developments
11.9 AnGes MG, Inc. (Japan)
11.9.1 AnGes MG, Inc. (Japan) Company Information
11.9.2 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AnGes MG, Inc. (Japan) Main Business Overview
11.9.5 AnGes MG, Inc. (Japan) Latest Developments
11.10 Athersys, Inc. (US)
11.10.1 Athersys, Inc. (US) Company Information
11.10.2 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Athersys, Inc. (US) Main Business Overview
11.10.5 Athersys, Inc. (US) Latest Developments
11.11 Betagenon AB (Sweden)
11.11.1 Betagenon AB (Sweden) Company Information
11.11.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Betagenon AB (Sweden) Main Business Overview
11.11.5 Betagenon AB (Sweden) Latest Developments
11.12 miRagen Therapeutics, Inc. (US)
11.12.1 miRagen Therapeutics, Inc. (US) Company Information
11.12.2 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 miRagen Therapeutics, Inc. (US) Main Business Overview
11.12.5 miRagen Therapeutics, Inc. (US) Latest Developments
11.13 Multi Gene Vascular Systems Ltd (Israel)
11.13.1 Multi Gene Vascular Systems Ltd (Israel) Company Information
11.13.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Multi Gene Vascular Systems Ltd (Israel) Main Business Overview
11.13.5 Multi Gene Vascular Systems Ltd (Israel) Latest Developments
11.14 ViroMed Co. Ltd. (Korea)
11.14.1 ViroMed Co. Ltd. (Korea) Company Information
11.14.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 ViroMed Co. Ltd. (Korea) Main Business Overview
11.14.5 ViroMed Co. Ltd. (Korea) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2030
2.1.2 Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
2.2.1 Anti-Platelet Drugs
2.2.2 Dual Antiplatelet Therapy Drugs
2.2.3 Others
2.3 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
2.3.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
2.5.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
3 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Players
3.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS BY REGIONS
4.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth (2019-2024)
4.3 APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth (2019-2024)
4.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2019-2024)
5.2 Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024)
5.3 Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2019-2024)
6.2 APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024)
6.3 APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peripheral Arterial Disease (PAD) Therapeutics by Country (2019-2024)
7.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024)
7.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET FORECAST
10.1 Global Peripheral Arterial Disease (PAD) Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Peripheral Arterial Disease (PAD) Therapeutics Forecast
10.1.3 APAC Peripheral Arterial Disease (PAD) Therapeutics Forecast
10.1.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Forecast
10.1.5 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Forecast
10.2 Americas Peripheral Arterial Disease (PAD) Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.2.2 Canada Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.2.3 Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.2.4 Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3 APAC Peripheral Arterial Disease (PAD) Therapeutics Forecast by Region (2025-2030)
10.3.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.3 Korea Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.4 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.5 India Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.3.6 Australia Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4.2 France Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4.3 UK Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4.4 Italy Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.4.5 Russia Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5.2 South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5.3 Israel Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5.4 Turkey Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.5.5 GCC Countries Peripheral Arterial Disease (PAD) Therapeutics Market Forecast
10.6 Global Peripheral Arterial Disease (PAD) Therapeutics Forecast by Type (2025-2030)
10.7 Global Peripheral Arterial Disease (PAD) Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca Plc. (UK)
11.1.1 AstraZeneca Plc. (UK) Company Information
11.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Plc. (UK) Main Business Overview
11.1.5 AstraZeneca Plc. (UK) Latest Developments
11.2 Bayer HealthCare Pharmaceuticals (Germany)
11.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Information
11.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bayer HealthCare Pharmaceuticals (Germany) Main Business Overview
11.2.5 Bayer HealthCare Pharmaceuticals (Germany) Latest Developments
11.3 Bristol-Myers Squibb Company (US)
11.3.1 Bristol-Myers Squibb Company (US) Company Information
11.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bristol-Myers Squibb Company (US) Main Business Overview
11.3.5 Bristol-Myers Squibb Company (US) Latest Developments
11.4 Merck & Co., Inc. (US)
11.4.1 Merck & Co., Inc. (US) Company Information
11.4.2 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck & Co., Inc. (US) Main Business Overview
11.4.5 Merck & Co., Inc. (US) Latest Developments
11.5 Proteon Therapeutics, Inc. (US)
11.5.1 Proteon Therapeutics, Inc. (US) Company Information
11.5.2 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Proteon Therapeutics, Inc. (US) Main Business Overview
11.5.5 Proteon Therapeutics, Inc. (US) Latest Developments
11.6 Sanofi S.A. (France)
11.6.1 Sanofi S.A. (France) Company Information
11.6.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sanofi S.A. (France) Main Business Overview
11.6.5 Sanofi S.A. (France) Latest Developments
11.7 Symic Bio, Inc. (US)
11.7.1 Symic Bio, Inc. (US) Company Information
11.7.2 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Symic Bio, Inc. (US) Main Business Overview
11.7.5 Symic Bio, Inc. (US) Latest Developments
11.8 TheraVasc Inc. (US)
11.8.1 TheraVasc Inc. (US) Company Information
11.8.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 TheraVasc Inc. (US) Main Business Overview
11.8.5 TheraVasc Inc. (US) Latest Developments
11.9 AnGes MG, Inc. (Japan)
11.9.1 AnGes MG, Inc. (Japan) Company Information
11.9.2 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AnGes MG, Inc. (Japan) Main Business Overview
11.9.5 AnGes MG, Inc. (Japan) Latest Developments
11.10 Athersys, Inc. (US)
11.10.1 Athersys, Inc. (US) Company Information
11.10.2 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Athersys, Inc. (US) Main Business Overview
11.10.5 Athersys, Inc. (US) Latest Developments
11.11 Betagenon AB (Sweden)
11.11.1 Betagenon AB (Sweden) Company Information
11.11.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Betagenon AB (Sweden) Main Business Overview
11.11.5 Betagenon AB (Sweden) Latest Developments
11.12 miRagen Therapeutics, Inc. (US)
11.12.1 miRagen Therapeutics, Inc. (US) Company Information
11.12.2 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 miRagen Therapeutics, Inc. (US) Main Business Overview
11.12.5 miRagen Therapeutics, Inc. (US) Latest Developments
11.13 Multi Gene Vascular Systems Ltd (Israel)
11.13.1 Multi Gene Vascular Systems Ltd (Israel) Company Information
11.13.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Multi Gene Vascular Systems Ltd (Israel) Main Business Overview
11.13.5 Multi Gene Vascular Systems Ltd (Israel) Latest Developments
11.14 ViroMed Co. Ltd. (Korea)
11.14.1 ViroMed Co. Ltd. (Korea) Company Information
11.14.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
11.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 ViroMed Co. Ltd. (Korea) Main Business Overview
11.14.5 ViroMed Co. Ltd. (Korea) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anti-Platelet Drugs
Table 3. Major Players of Dual Antiplatelet Therapy Drugs
Table 4. Major Players of Others
Table 5. Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Products Offered
Table 14. Peripheral Arterial Disease (PAD) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Peripheral Arterial Disease (PAD) Therapeutics
Table 46. Key Market Challenges & Risks of Peripheral Arterial Disease (PAD) Therapeutics
Table 47. Key Industry Trends of Peripheral Arterial Disease (PAD) Therapeutics
Table 48. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. AstraZeneca Plc. (UK) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 53. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 54. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. AstraZeneca Plc. (UK) Main Business
Table 56. AstraZeneca Plc. (UK) Latest Developments
Table 57. Bayer HealthCare Pharmaceuticals (Germany) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 58. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 59. Bayer HealthCare Pharmaceuticals (Germany) Main Business
Table 60. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Bayer HealthCare Pharmaceuticals (Germany) Latest Developments
Table 62. Bristol-Myers Squibb Company (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 63. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 64. Bristol-Myers Squibb Company (US) Main Business
Table 65. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bristol-Myers Squibb Company (US) Latest Developments
Table 67. Merck & Co., Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 68. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 69. Merck & Co., Inc. (US) Main Business
Table 70. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Merck & Co., Inc. (US) Latest Developments
Table 72. Proteon Therapeutics, Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 73. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 74. Proteon Therapeutics, Inc. (US) Main Business
Table 75. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Proteon Therapeutics, Inc. (US) Latest Developments
Table 77. Sanofi S.A. (France) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 78. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 79. Sanofi S.A. (France) Main Business
Table 80. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Sanofi S.A. (France) Latest Developments
Table 82. Symic Bio, Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 83. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 84. Symic Bio, Inc. (US) Main Business
Table 85. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Symic Bio, Inc. (US) Latest Developments
Table 87. TheraVasc Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 88. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 89. TheraVasc Inc. (US) Main Business
Table 90. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. TheraVasc Inc. (US) Latest Developments
Table 92. AnGes MG, Inc. (Japan) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 93. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 94. AnGes MG, Inc. (Japan) Main Business
Table 95. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. AnGes MG, Inc. (Japan) Latest Developments
Table 97. Athersys, Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 98. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 99. Athersys, Inc. (US) Main Business
Table 100. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Athersys, Inc. (US) Latest Developments
Table 102. Betagenon AB (Sweden) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 103. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 104. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Betagenon AB (Sweden) Main Business
Table 106. Betagenon AB (Sweden) Latest Developments
Table 107. miRagen Therapeutics, Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 108. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 109. miRagen Therapeutics, Inc. (US) Main Business
Table 110. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. miRagen Therapeutics, Inc. (US) Latest Developments
Table 112. Multi Gene Vascular Systems Ltd (Israel) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 113. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 114. Multi Gene Vascular Systems Ltd (Israel) Main Business
Table 115. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Multi Gene Vascular Systems Ltd (Israel) Latest Developments
Table 117. ViroMed Co. Ltd. (Korea) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 118. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 119. ViroMed Co. Ltd. (Korea) Main Business
Table 120. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. ViroMed Co. Ltd. (Korea) Latest Developments
Table 1. Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anti-Platelet Drugs
Table 3. Major Players of Dual Antiplatelet Therapy Drugs
Table 4. Major Players of Others
Table 5. Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Peripheral Arterial Disease (PAD) Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Products Offered
Table 14. Peripheral Arterial Disease (PAD) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Peripheral Arterial Disease (PAD) Therapeutics
Table 46. Key Market Challenges & Risks of Peripheral Arterial Disease (PAD) Therapeutics
Table 47. Key Industry Trends of Peripheral Arterial Disease (PAD) Therapeutics
Table 48. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. AstraZeneca Plc. (UK) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 53. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 54. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. AstraZeneca Plc. (UK) Main Business
Table 56. AstraZeneca Plc. (UK) Latest Developments
Table 57. Bayer HealthCare Pharmaceuticals (Germany) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 58. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 59. Bayer HealthCare Pharmaceuticals (Germany) Main Business
Table 60. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Bayer HealthCare Pharmaceuticals (Germany) Latest Developments
Table 62. Bristol-Myers Squibb Company (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 63. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 64. Bristol-Myers Squibb Company (US) Main Business
Table 65. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bristol-Myers Squibb Company (US) Latest Developments
Table 67. Merck & Co., Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 68. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 69. Merck & Co., Inc. (US) Main Business
Table 70. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Merck & Co., Inc. (US) Latest Developments
Table 72. Proteon Therapeutics, Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 73. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 74. Proteon Therapeutics, Inc. (US) Main Business
Table 75. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Proteon Therapeutics, Inc. (US) Latest Developments
Table 77. Sanofi S.A. (France) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 78. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 79. Sanofi S.A. (France) Main Business
Table 80. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Sanofi S.A. (France) Latest Developments
Table 82. Symic Bio, Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 83. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 84. Symic Bio, Inc. (US) Main Business
Table 85. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Symic Bio, Inc. (US) Latest Developments
Table 87. TheraVasc Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 88. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 89. TheraVasc Inc. (US) Main Business
Table 90. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. TheraVasc Inc. (US) Latest Developments
Table 92. AnGes MG, Inc. (Japan) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 93. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 94. AnGes MG, Inc. (Japan) Main Business
Table 95. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. AnGes MG, Inc. (Japan) Latest Developments
Table 97. Athersys, Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 98. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 99. Athersys, Inc. (US) Main Business
Table 100. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Athersys, Inc. (US) Latest Developments
Table 102. Betagenon AB (Sweden) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 103. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 104. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Betagenon AB (Sweden) Main Business
Table 106. Betagenon AB (Sweden) Latest Developments
Table 107. miRagen Therapeutics, Inc. (US) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 108. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 109. miRagen Therapeutics, Inc. (US) Main Business
Table 110. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. miRagen Therapeutics, Inc. (US) Latest Developments
Table 112. Multi Gene Vascular Systems Ltd (Israel) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 113. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 114. Multi Gene Vascular Systems Ltd (Israel) Main Business
Table 115. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Multi Gene Vascular Systems Ltd (Israel) Latest Developments
Table 117. ViroMed Co. Ltd. (Korea) Details, Company Type, Peripheral Arterial Disease (PAD) Therapeutics Area Served and Its Competitors
Table 118. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Offered
Table 119. ViroMed Co. Ltd. (Korea) Main Business
Table 120. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. ViroMed Co. Ltd. (Korea) Latest Developments
LIST OF FIGURES
Figure 1. Peripheral Arterial Disease (PAD) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Peripheral Arterial Disease (PAD) Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type in 2023
Figure 10. Peripheral Arterial Disease (PAD) Therapeutics in Hospitals
Figure 11. Global Peripheral Arterial Disease (PAD) Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Peripheral Arterial Disease (PAD) Therapeutics in Clinics
Figure 13. Global Peripheral Arterial Disease (PAD) Therapeutics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Peripheral Arterial Disease (PAD) Therapeutics in Others
Figure 15. Global Peripheral Arterial Disease (PAD) Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Peripheral Arterial Disease (PAD) Therapeutics Value Market Share by Country in 2023
Figure 24. United States Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Peripheral Arterial Disease (PAD) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Peripheral Arterial Disease (PAD) Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type in 2023
Figure 10. Peripheral Arterial Disease (PAD) Therapeutics in Hospitals
Figure 11. Global Peripheral Arterial Disease (PAD) Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Peripheral Arterial Disease (PAD) Therapeutics in Clinics
Figure 13. Global Peripheral Arterial Disease (PAD) Therapeutics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Peripheral Arterial Disease (PAD) Therapeutics in Others
Figure 15. Global Peripheral Arterial Disease (PAD) Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Peripheral Arterial Disease (PAD) Therapeutics Value Market Share by Country in 2023
Figure 24. United States Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Peripheral Arterial Disease (PAD) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Organic Yogurt Market Growth 2023-2029
US$ 3,660.00
March 2023
115 pages
Global Acetohydroxamic Acid Market Growth 2025-2031
US$ 3,660.00
October 2025
104 pages
Global Axial Bone Densitometer Market Growth 2024-2030
US$ 3,660.00
March 2024
90 pages
Global Corticosteroids Market Growth 2025-2031
US$ 3,660.00
October 2025
89 pages
Global NIBP Patient Monitor Market Growth 2023-2029
US$ 3,660.00
February 2023
114 pages
